Catherine Julien
Affiliations: | 2014-2016 | Molecular Physiology | IRCM |
Google:
"Catherine Julien"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Mathieu Ferron | research assistant | 2014-2016 | IRCM |
| Sylvain Meloche | grad student | Université de Montréal (Microtree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Al Rifai O, Julien C, Lacombe J, et al. (2020) The half-life of the bone-derived hormone osteocalcin is regulated through -glycosylation in mice, but not in humans. Elife. 9 |
| El-Rifai O, Chow J, Lacombe J, et al. (2017) Proprotein convertase furin regulates osteocalcin and bone endocrine function. The Journal of Clinical Investigation |
| Voisin L, Saba-El-Leil MK, Julien C, et al. (2010) Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Molecular and Cellular Biology. 30: 2918-32 |
| Boutonnet C, Tanguay PL, Julien C, et al. (2010) Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2. Cell Cycle (Georgetown, Tex.). 9: 975-9 |
| Voisin L, Julien C, Duhamel S, et al. (2008) Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. Bmc Cancer. 8: 337 |
| Aberg E, Perander M, Johansen B, et al. (2006) Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4. The Journal of Biological Chemistry. 281: 35499-510 |
| Pelletier S, Julien C, Popoff MR, et al. (2005) Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway. Journal of Cellular Physiology. 204: 412-22 |
| Julien C, Coulombe P, Meloche S. (2003) Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression. The Journal of Biological Chemistry. 278: 42615-24 |